In addition to NMDARs themselves, downstream molecules of NMDARs are also targets of drug design, and inhibiting nNOS showed protective effects in Alzheimer's disease model mice (Misra, Kuhad & Chopra, 2013; Yu et al., 2013). This evidence concerns the gene NOS1 and Alzheimer disease.